BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18397335)

  • 1. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
    Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR
    Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
    J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis.
    Serena C; Rodríguez MM; Mariné M; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):877-9. PubMed ID: 18276603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
    Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
    Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis.
    Adler-Moore JP; Olson JA; Proffitt RT
    J Antimicrob Chemother; 2004 Dec; 54(6):1096-102. PubMed ID: 15509617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds.
    Maki K; Matsumoto S; Watabe E; Iguchi Y; Tomishima M; Ohki H; Yamada A; Ikeda F; Tawara S; Mutoh S
    Microbiol Immunol; 2008 Aug; 52(8):383-91. PubMed ID: 18667037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy in treatment of murine infection by Fusarium solani.
    Ruíz-Cendoya M; Mariné M; Guarro J
    J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model.
    Bayegan S; Szilágyi J; Kemény-Beke Á; Földi R; Kardos G; Gesztelyi R; Juhasz B; Adnan A; Majoros L
    J Chemother; 2011 Apr; 23(2):107-9. PubMed ID: 21571628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
    Hope WW; Drusano GL; Moore CB; Sharp A; Louie A; Walsh TJ; Denning DW; Warn PA
    Antimicrob Agents Chemother; 2007 Jan; 51(1):285-95. PubMed ID: 17088486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
    Krishnan-Natesan S; Manavathu EK; Cutright JL; Chandrasekar PH
    Int J Antimicrob Agents; 2010 Jul; 36(1):33-6. PubMed ID: 20400270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis.
    Lewis RE; Albert ND; Kontoyiannis DP
    J Antimicrob Chemother; 2008 May; 61(5):1140-4. PubMed ID: 18305201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
    Ninomiya M; Mikamo H; Tanaka K; Watanabe K; Tamaya T
    J Antimicrob Chemother; 2005 Apr; 55(4):587-90. PubMed ID: 15728144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
    Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
    J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.